EMCURE
NSEEmcure Pharmaceuticals Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,814.40
4.90 (0.27%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹34.40K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
36.5
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,260+44.0%
52W High₹1,944-6.7%
Current Price
₹1,814.40
Circuit Limits (10%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,632.96
Upper Circuit₹1,995.84
Reference Price
₹1,814.40
Investment Checklist
Rising Wedge on 1D — target ₹1544.2
Double Bottom on 1D — target ₹1969.0
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 40.87 (BUY) with 84.5% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
85%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
1804.02
EMA50
1746.82
EMA200
1570.53
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows4
Lower Highs6
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹1824.00
₹1944.00
Support (Below)
₹1757.90
₹1677.60
₹1585.60
₹1565.20
₹1543.00
Volume Analysis
TrendDECREASING
Change-55.10%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹1796.26
3% Risk₹1759.97
5% Risk₹1723.68
7% Risk (Custom)
₹1687.39Technical Levels
1x ATR (Volatility)₹1759.12
2x ATR (Swing)₹1703.84
3x ATR (Trend)₹1648.56
Immediate Support₹1757.90
Moving Averages
EMA 20 (Medium-term)₹1804.02
EMA 50 (Trend)₹1746.82
EMA 200 (Long-term)₹1570.53
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹2,028.5 Cr | ₹2,100.5 Cr | ₹2,269.8 Cr | ₹2,363.5 Cr |
| Net Profit | ₹189 Cr | ₹207 Cr | ₹243.5 Cr | ₹230.5 Cr |
| EPS | — | ₹10.92 | ₹12.85 | ₹12.16 |
| Operating Profit | ₹360.7 Cr | ₹417 Cr | ₹478.6 Cr | ₹456.4 Cr |
ROE
15.32%
ROCE
20.32%
Debt/Equity
0.23
Current Ratio
1.71
OPM
19.31%
NPM
9.75%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Emcure Pharmaceuticals Limited | ₹1,814.40 | +0.27% | 36.5 | ₹34.40K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 14 Aug 2025 | Dividend - Rs 3 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for EMCURE
View AllNEWS
neutral
Business Standard - Markets 1h ago
Gennova Biopharmaceuticals to transfer its mRNA business to Immunoscript Life Science
Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, has executed a Business Transfer Agreement for transfer of its mRNA business as a going concern on a slump sale basis for a cash consideration of Rs 139.5 crore to Immunoscript Life Science on 10 July2026.
CLSLEMCUREChemicalsHealthcare
positive
CNBC TV18 - Markets 15d ago
Bain Capital exits Emcure Pharma after selling remaining stake, ends 12-year bet
Shares of Emcure Pharmaceuticals Ltd ended at ₹1,881.90, up by ₹43.75, or 2.38%, on the BSE.
AKCAPITBSECPCAPECAPINSUREEMCUREFinancial ServicesHealthcare
positive
Google News - India Markets 16d ago
Stocks to buy or sell: Osho Krishan of Angel One suggests buying HDFC Bank, Emcure Pharma shares on 25 June - Mint
Stocks to buy or sell: Osho Krishan of Angel One suggests buying HDFC Bank, Emcure Pharma shares on 25 JuneMint
ANGELONEAONEGOLDAONELIQUIDAONENIFTYAONESILVERAONETMMQ50AONETOTALBANKINDIAEMCUREHDFCBANKHDFCNIFBANHDFCPSUBKHDFCPVTBANFinancial ServicesHealthcare